C Vanchieri. Show Affiliations »
Abstract
Entities: Chemical
Mesh： See more » Drug ApprovalErythema Nodosum/drug therapyFemaleHumansLeprostatic Agents/adverse effectsLeprostatic Agents/therapeutic useLeprosy, Lepromatous/drug therapyMaleThalidomide/adverse effectsThalidomide/therapeutic useUnited StatesUnited States Food and Drug Administration
Substances： See more » Leprostatic AgentsThalidomide
Year: 1997 PMID： 9446509 DOI： 10.7326/0003-4819-127-10-199711150-00023
Source DB: PubMed Journal: Ann Intern Med ISSN： 0003-4819 Impact factor: 25.391